MedTrace Logo

A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers

NCT01281774 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2012-03-07

No results posted yet for this study

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of CSL112 in healthy volunteers after multiple infusions.

Conditions

  • Healthy

Interventions

BIOLOGICAL

CSL112

reconstituted high density lipoprotein

BIOLOGICAL

Placebo

Normal saline (0.9%)

Sponsors & Collaborators

Principal Investigators

  • Senior Director, Cardiovascular · CSL Limited

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01281774 on ClinicalTrials.gov